Cargando…

Experiences with Continuous Venovenous Hemofiltration using 18mmol/L predilution Citrate anticoagulation and a Phosphate Containing Replacement Solution

CONTEXT: Regional citrate anticoagulation for continuous renal replacement therapy is associated with a longer filter-life, less bleeding events and improved mortality. Problems associated with using Prismocitrate 10/2 solution in continuous renal replacement therapy, include hypomagnesemia, hypopho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeffrey, Yuen Henry, Hoi-Ping, Shum, Kit Hung, Anne Leung, Chung-Ling, Lam, Wing-Wa, Yan, King-Yiu, Lai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278584/ https://www.ncbi.nlm.nih.gov/pubmed/28197045 http://dx.doi.org/10.4103/0972-5229.198311

Ejemplares similares

A Retrospective Review of the Use of Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration for Critically Ill Patients
por: Leung, Anne Kit-Hung, et al.
Publicado: (2013)

Regional citrate anticoagulation with a low-concentration solution in predilution-postdilution CVVH
por: Pistolesi, V, et al.
Publicado: (2012)

Evaluation of the predilution technique in reducing the occurrence of bleeding during continuous venovenous haemofiltration in critically ill patients. Efficacy of predilution in reducing the amount of anticoagulation during CVVH
por: Honore, PM, et al.
Publicado: (1997)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study
por: Yu, Yan, et al.
Publicado: (2020)

Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study
por: Yu, Yan, et al.
Publicado: (2020)

Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial
por: Ratanarat, Ranistha, et al.
Publicado: (2023)

Correction to: Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous venovenous hemofiltration
por: Jacobs, Rita, et al.
Publicado: (2020)

Negative calcium balance despite normal plasma ionized calcium concentrations during citrate anticoagulated continuous venovenous hemofiltration (CVVH) in ICU patients
por: de Jonge, Evert, et al.
Publicado: (2022)

Comparing adsorption of gentamicin by polyacrylonitrile and polyamide hemofiltration filter in an in vitro continuous venovenous hemofiltration model
por: Lam, P, et al.
Publicado: (2009)

The effects of continuous venovenous hemofiltration on coagulation activation
por: Bouman, Catherine SC, et al.
Publicado: (2006)

Regional citrate anticoagulation in high-volume continuous venovenous hemodialysis
por: Kalb, R, et al.
Publicado: (2011)

Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial
por: Schilder, Louise, et al.
Publicado: (2014)

Regional citrate anticoagulation with a substitute containing calcium for continuous hemofiltration in children
por: Bai, Ke, et al.
Publicado: (2019)

The removal of cystatin C during continuous venovenous hemofiltration
por: Bouman, Catherine S. C., et al.
Publicado: (2011)

Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
por: Köglberger, Paul, et al.
Publicado: (2021)

Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2009)

Dynamics of the dosage of citrate-calciuminfusion regimens as anticoagulation in continuous venovenous hemodiafiltration
por: Marin Mateos, H, et al.
Publicado: (2015)

Continuous venovenous hemofiltration using customized replacement fluid for acute kidney injury with severe hypernatremia
por: Paquette, François, et al.
Publicado: (2016)

High-dose continuous venovenous hemofiltration combined with charcoal hemoperfusion for methotrexate removal
por: Grafft, Carrie, et al.
Publicado: (2011)

A comparison between 2 dilute citrate solutions (15mmol/l vs 18 mmol/l) in continuous renal replacement therapy: the base excess and renal replacement solution (BEARRS) study
por: Anstey, CM, et al.
Publicado: (2015)

Influence of continuous venovenous hemofiltration on transpulmonary thermodilution-derived parameters
por: Neirynck, V, et al.
Publicado: (2009)

Methotrexate toxicity treated with continuous venovenous hemofiltration, leucovorin and glucarpidase
por: Connors, Nicholas J., et al.
Publicado: (2014)

Bioenergetic Balance of Continuous Venovenous Hemofiltration, a Retrospective Analysis
por: Jonckheer, Joop, et al.
Publicado: (2022)

Regional citrate anticoagulation (RCA) for continuous venovenous hemodiafiltration (CVVHDF): initial experience
por: Durão, M, et al.
Publicado: (2001)

Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
por: Lenga, Ilan, et al.
Publicado: (2019)

Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
por: Meyer, B, et al.
Publicado: (2004)

Immunomodulatory Effect of Continuous Venovenous Hemofiltration during Sepsis: Preliminary Data
por: Servillo, Giuseppe, et al.
Publicado: (2013)

Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Park, Joon-Sung, et al.
Publicado: (2011)

Rapid calcium loss may cause arrhythmia in hemofiltration with regional citrate anticoagulation: a case report
por: Wu, Buyun, et al.
Publicado: (2018)

Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation
por: Margraf, Andreas, et al.
Publicado: (2022)

Putative novel mediators of acute kidney injury in critically ill patients: handling by continuous venovenous hemofiltration and effect of anticoagulation modalities
por: Schilder, Louise, et al.
Publicado: (2015)

Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
por: Slowinski, Torsten, et al.
Publicado: (2015)

Continuous venovenous hemofiltration versus extended daily hemofiltration in patients with septic acute kidney injury: a retrospective cohort study
por: Sun, Zhiping, et al.
Publicado: (2014)

Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation
por: dos Santos, Thais Oliveira Claizoni, et al.
Publicado: (2023)

Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid–base status and phosphate supplementation needs
por: Morabito, Santo, et al.
Publicado: (2013)

Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study
por: de Pont, Anne-Cornélie JM, et al.
Publicado: (2007)

Effects of continuous venovenous hemofiltration on vancomycin trough concentrations in critically ill children
por: Peng, Lengyue, et al.
Publicado: (2021)

Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid
por: Morabito, S, et al.
Publicado: (2012)

Regional citrate anticoagulation in CVVH: A new protocol combining citrate solution with a phosphate-containing replacement fluid
por: Morabito, Santo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5skbdju5rsgulp9rst96ook0it